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Retinal ganglion cells (RGCs) consume large quantities of energy to convert light
information into a neuronal signal, which makes them highly susceptible to hypoxic
injury. This study aimed to investigate the potential protection by baclofen, a GABAB
receptor agonist of RGCs against hypoxia-induced apoptosis. Cobalt chloride (CoCl2)
was applied to mimic hypoxia. Primary rat RGCs were subjected to CoCl2 with or
without baclofen treatment, and RNA interference techniques were used to knock
down the GABAB2 gene in the primary RGCs. The viability and apoptosis of RGCs
were assessed using cell viability and terminal deoxynucleotidyl transferase-mediated
dUTP nick end-labeling (TUNEL) assays, Hoechst staining, and flow cytometry. The
expression of cleaved caspase-3, bcl-2, bax, Akt, phospho-Akt, protein kinase RNA
(PKR)-like ER kinase (PERK), phospho-PERK, eIF2α, phospho-eIF2α, ATF-4 and
CCAAT/enhancer-binding protein homologous protein (CHOP) were measured using
western blotting. GABAB2 mRNA expression was determined using quantitative
real-time polymerase chain reaction (qRT-PCR) analysis. Our study revealed that CoCl2
significantly induced RGC apoptosis and that baclofen reversed these effects. CoCl2-
induced reduction of Akt activity was also reversed by baclofen. Baclofen prevented
the activation of the PERK pathway and the increase in CHOP expression induced by
CoCl2. Knockdown of GABAB2 and the inactivation of the Akt pathway by inhibitors
reduced the protective effect of baclofen on CoCl2-treated RGCs. Taken together,
these results demonstrate that baclofen protects RGCs from CoCl2-induced apoptosis
by increasing Akt activity and by suppressing the PERK pathway and CHOP activation.
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INTRODUCTION
The retina is the most metabolically active tissue in human body (Ames, 1992; Caprara and
Grimm, 2012). In retinal disease such as retinopathy of prematurity, diabetic retinopathy,
age-related macular degeneration and glaucoma, an insufficient supply of oxygen or nutrients,
may occur during conditions of disturbed hemodynamics or vascular defects, results in highly
impaired cellular oxygen balance, and retinal neurons become hypoxic (Kaur et al., 2009, 2012;
Munemasa and Kitaoka, 2012). Among the retinal neurons, retinal ganglion cells (RGCs) are the
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predominant components that undergo hypoxic injury (Abu-El-
Asrar et al., 2004; Caprara and Grimm, 2012; Munemasa and
Kitaoka, 2012), for they are the ultimate neurons in retina that
consume large quantities of energy to convey visual information
to the brain (Sanes and Masland, 2015). Hypoxia-related
disorders enhance or induce the death of RGCs in the retina,
resulting in irreversible vision loss, most of which through
apoptosis (Kaur et al., 2009; Yang et al., 2013).
Several hypoxic chemicals have been used to explore the
molecular events that underlie the hypoxic neuronal death (Kim
et al., 2015). Among all the divalent cations that act as hypoxic
mimetics, Cobalt chloride (CoCl2) has shown to induce hypoxia
(Yan et al., 2005; Cascio et al., 2008; Law et al., 2012; Lopez-
Sánchez et al., 2014) by increasing HIF1α stability and degrading
HIF1α (Carbajo-Pescador et al., 2013; Kim et al., 2015; Masoud
and Li, 2015). In the present study, RGCswere treated with CoCl2
to stimulate hypoxia.
Gamma-aminobutyric acid (GABA) is the main inhibitory
neurotransmitter involved in neuronal information processing
within the retina (Koulen et al., 1998), and ganglion cells,
along with other types of retinal neurons receiving input
from GABAergic cells (Nag and Wadhwa, 1997; Koulen et al.,
1998). GABA mediates its actions via distinct receptor systems,
including the ionotropic GABAA and GABAC receptors and the
metabotropic GABAB receptor. The GABAB receptor belongs to
the class C G-protein-coupled receptors and is composed of two
subunits—GABAB1 and GABAB2—both of which are required
for normal receptor function (Bettler et al., 2004; Liu et al., 2004;
Pin et al., 2004).
Recent advances indicate that GABA can act beyond its
classical role in synaptic communication and may modulate
nearly all critical steps of neuronal network formation including
neurodegenerative, neuroinflammatory and neuromigration
(Gaiarsa and Porcher, 2013; Crowley et al., 2015). Accumulating
evidences have shown that specific activation of GABAB receptor
can protect neurons from apoptosis under metabolic stress (Tu
et al., 2010; Naseer et al., 2013; Shilpa et al., 2013). Baclofen
is a stereoselective GABAB receptor agonist that reduces the
release of excitatory neurotransmitters and substances (Albright,
1996; Krach, 2001). It is a drug approved by the Food and
Drug Administration that has been used to control spasticity
(Furr-Stimming et al., 2014; Crowley et al., 2015) and in the
treatment of pain management (Ward and Kadies, 2002) and
alcohol addiction (Howland, 2012). Studies have demonstrated
a neuroprotective effect of baclofen through the activation of
GABAB receptor (Babcock et al., 2002; Tyurenkov et al., 2012;
Naseer et al., 2013). It has been reported that the upregulation
of GABAB receptor activity could inhibit NMDA-receptor-
mediated nitric oxide (NO) production by neuronal NO synthase
(nNOS) in brain ischemic injury (Zhou et al., 2008). Recent
studies have revealed that, under chronic cerebral hypoperfusion,
the effects of GABAB receptors activated by baclofen could
reverse neuronal damage by increasing the activation of Akt,
GSK-3β and ERK and upregulating the bcl-2/bax ratio, which
suppress cytodestructive autophagy (Liu et al., 2015). Another
study has shown that baclofen markedly improves memory
impairment and alleviates neuronal damage in chronic ischemic
rats by increasing the expression and regulating the function of
the TPR-containing Rab8b-interacting protein (TRIP8b; Li et al.,
2014b).
Given previous reports linking protective effects of baclofen
and neurons with hypoxic injuries, particularly with relevance
to neuron apoptosis, it is therefore rational to hypothesized
that baclofen might have similar neuroprotective effects on
RGCs undergo hypoxic stress. In the present investigation, we
explored the impact of baclofen on the cobalt-induced hypoxic
RGCs, using primary rat ganglion cells isolated from neonatal
Sprague-Dawley (SD) rats. In addition, the relevant molecular
pathways associated with the neuroprotective effects of baclofen
were evaluated.
MATERIALS AND METHODS
Purified Rat Retinal Ganglion Cell Culture
All animal experiments were approved by the Animal
Experimentation Ethics Committee of the Sixth People’s
Hospital, Shanghai Jiao Tong University and were carried out
in accordance with the approved guidelines for the Care and
Use of Laboratory Animals of the National Institutes of Health
(Bethesda, MD, USA). Primary RGC cultures were established as
previously described (Yamagishi and Aihara, 2014), with some
modification. Briefly, retinas were dissected from the eyes of
1- to 4-day-old SD rats (SIPPR/BK Lab Animal Ltd, Shanghai,
China). This was followed by a two-step immunopanning
procedure, as described below (Yamagishi and Aihara, 2014).
Retinal tissues were incubated at 37◦C for 30 min in a solution
containing 5 mg/ml papain (all reagents were obtained from
Sigma Aldrich, St Louis, MO, USA, unless otherwise stated)
in minimum essential medium (MEM; Gibco, Grand Island,
NY, USA). To obtain a single cell suspension, tissues were
then sequentially triturated through a narrow-bore Pasteur
pipette in an ovomucoid solution. After centrifugation at
400× g for 10 min, cells were resuspended in 0.1% bovine
serum albumin (BSA) in MEM. Antibodies were then removed,
and the cell suspension was incubated in an anti-macrophage
antibody-coated (Abcam, Cambridge, MA, USA) flask for 1 h
at room temperature and in an anti-Thy1.1 antibody-coated
(Abcam, Cambridge, MA, USA) flask for 1 h at 37◦C. Cells
adhering to the flask (RGCs) were resuspended in a base
medium (Neurobasal medium (Gibco, Grand Island, NY, USA)
containing 2% B27, 0.1 mg/ml BSA, 0.1 mg/ml transferrin, 1 mM
L-glutamine, 5 µg/ml insulin, 1 mM sodium pyruvate, 40 ng/ml
triiodothyronine, 40 ng/mL thyroxine, 60 ng/ml progesterone, 16
µg/ml putrescine, 40 ng/ml sodium selenite, 60 µg/ml N-acetyl
cysteine, 50 ng/ml brain derived neurotrophic factor (BDNF),
10 ng/ml basic fibroblast growth factor (bFGF), 10 ng/ml
ciliary-derived neurotrophic factor (CNTF), 5 mM Forskolin,
100 units/mL penicillin, and 100 mg/mL streptomycin), seeded
onto plates that had been coated with 0.05 mg/ml poly-L-lysine
overnight, and rinsed twice with sterile deionized water. RGCs
were cultured for 48 h at 37◦C in a humidified incubator with
5% CO2 in base medium before each experiment. Cultures were
washed once with phosphate-buffered saline (PBS; Gibco, Grand
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Island, NY, USA) and pre-incubated at 37◦C in neurobasal
medium for 60 min before drug treatment. Drugs were freshly
prepared and dissolved in serum-free neurobasal medium
containing 2% B27. Drug treatments were as follows: MK-2206
2HCl (5 µM, 24 h; Selleckchem, Houston, TX, USA); CoCl2
(for the indicated concentrations and times); baclofen (for the
indicated concentrations and times).
Cell Viability Assay
Cell viability was measured using Cell Counting Kit-8 (CCK-
8; Dojindo, Japan) according to the manufacturer’s instructions.
The CCK-8 assay was performed in a 96-well culture plate with
three replicates for each condition at an absorbance of 450 nm.
The number of living cells in each well was expressed as the value
relative to the control.
Small Interfering RNA Transfection
Small interfering RNA (siRNA) targeted against GABAB2 and
scrambled small hairpin RNA (shRNA) were designed and
packaged by Genechem Co., Ltd (Shanghai, China). The
sequences used were as follows: rat GABAB2 siRNA1 (5′-CCA
AGG ACA AGA CCA UCA UTT-3′), siRNA2 (5′-CCA AAC
AAA UCA AGA CCA UTT -3′), siRNA3 (5′-CCG AGU GUG
ACA AUG CAA ATT-3′), and negative control (5′-UUC UCC
GAA CGU GUC ACG UTT -3′). Transfection was performed
with Lipofectamine 2000 (Thermo Fisher Scientific, Shanghai,
China) according to the manufacturer’s instruction. Forty-eight
hours after transfection, the medium was replaced and the cells
were treated with CoCl2 and baclofen as described above.
TUNEL Assay
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL) staining was used to detect
apoptosis-specific nuclear DNA fragmentation. Cells were fixed
in 4% paraformaldehyde for 20 min at room temperature before
TUNEL staining. The fixed cells were then stained using a
commercial TUNEL kit (In Situ Cell Death Detection Kit; Boster,
Wuhan, China) according to the manufacturer’s recommended
instructions. TUNEL-positive cell nuclei were visualized based
on green fluorescence and imaging was performed under
40× magnification. The percentage of TUNEL-positive cells
was calculated in five microscopic fields from each slide. The
population of TUNEL-positive cells was also quantified by flow
cytometry.
Hoechst Stain
After being fixed with 4% paraformaldehyde at 4◦C for 30 min,
cells were incubated with the DNA stain Hoechst 33,342
(Beyotime, Shanghai, China) for 10 min at room temperature
and mounted with a fluorescent mounting medium (Beyotime,
Shanghai, China). Images were acquired using a fluorescence
microscope (Olympus, Shinjuku, Japan).
Apoptosis Detection by Flow Cytometry
Apoptosis was measured using a fluorescein isothiocyanate
(FITC) Annexin V Apoptosis Detection Kit (BD Biosciences, San
Diego, CA, USA) according to the manufacturer’s instructions.
Cells were incubated in trypsin-EDTA, collected and suspended
in 1× annexin V binding buffer. One hundred microliters
of each cell suspension was incubated with 5 µl annexin
V-FITC and 5 µl propidium iodide (PI) at room temperature
in the dark for 15 min. Following this incubation, 400 µl
of 1× binding buffer was added to each tube, and samples
were analyzed using FACS. Each experiment was repeated in
triplicate.
Western Blot Analysis
After each treatment, RGCs were harvested and lysed in
RIPA buffer (1% Nonidet P-40, 0.5% sodium deoxycholate,
0.1% SDS in PBS) and centrifuged at 12,000 rpm for
20 min at 4◦C. Protein was extracted, and equal amounts
of protein (30 µg per lane) were separated by 8% or
10% SDS-PAGE and transferred onto polyvinylidene fluoride
membranes (Millipore). The membranes were blocked with 5%
nonfat milk for 1 h and then incubated overnight at 4◦C with
the following primary antibodies (all antibodies were obtained
from Cell Signaling Technology Inc., Danvers, MA, USA,
unless otherwise stated): rabbit anti-cleaved caspase-3 (1:1000),
rabbit anti-bcl-2 (1:1000), rabbit anti-bax (1:1000), rabbit
anti-Akt (1:1000), mouse anti-phospho-Akt (1:1000), rabbit
anti-protein kinase RNA (PKR)-like ER kinase (PERK) (1:1000),
rabbit anti-phospho-PERK (1:1000), rabbit anti-eIF2α (1:1000),
rabbit anti-phospho-eIF2α (1:1000), rabbit anti-ATF-4 (1:1000),
and rabbit anti-CHOP (1:1000; Abcam, Cambridge, MA, USA).
After the membranes were washed, a goat anti-rabbit or
goat anti-mouse horseradish peroxidase-conjugated secondary
antibody (1:2000; Proteintech Group, Chicago, IL, USA) was
applied, and proteins were visualized using an enhanced
chemiluminescence detection system (Bio-Rad, Hercules, CA,
USA). Band intensity was analyzed with Quantity One version
4.6.2 software (Bio-Rad) and comparedwith the α-tubulin (1:200;
Boster, Wuhan, China) internal standard.
RT-PCR
Harvested cells were washed with PBS, and total RNA was
extracted from cells using Trizol reagent (Invitrogen, Carlsbad,
CA, USA). The primer sequences used were as follows: rat
GABAB2 (forward: 5′-CGG AGG ACA GTG GAG AGG
TA-3′, reverse: 5′-AGA CAA TGC CAA GCC AGA TG-3′),
and rat β-actin (forward: 5′-CAC CCG CGA GTA CAA
CCT TC-3′, reverse: 5′-CCC ATA CCC ACC ATC ACA
CC-3′). Quantitative real-time polymerase chain reaction (qRT-
PCR) was performed using the SYBR Green quantitative
PCR (qPCR) Super Mixture (Takara, Tokyo, Japan) and
the ABI Prism 7500 Sequence Detection System (Applied
Biosystems, Foster City, CA, USA). All reactions were performed
in triplicate. The data were analyzed using the 2−11CT
method.
Statistical Analysis
All experiments were repeated at least three times, and
representative results are shown. The differences between two
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groups were compared with an independent-sample t-test (SPSS
19.0 software, Chicago, IL, USA). A two-tailed P < 0.05 was
considered to indicate statistical significance. Data are presented
as the means± standard deviation (SD).
RESULTS
CoCl2 Induces RGC Apoptosis
To establish a cell model for this study, we first assessed
the apoptotic response of RGCs to hypoxia-mimetic agent
cobalt. Different concentrations of CoCl2 (0, 100, 200, 400,
800 µM) were added to the RGC culture medium. The
CCK-8 assay was used to determine cell viability, and the
results showed that cell viability was significantly decreased
after 24 h of exposure to CoCl2 in a dose-dependent manner
(Figure 1A). Western blot analysis indicated that CoCl2
stimulation not only increased the level of cleaved caspase-3
and bax proteins, but also decreased the level of bcl-2 protein
in a dose-dependent manner (Figures 1B,C). We noticed that,
at a concentration of 200 µM of CoCl2, RGC viability was not
significantly impaired even though the level of apoptosis-related
proteins had been obviously changed. Furthermore, annexin
V/PI double-stained flow cytometry was used to evaluate the
CoCl2-induced apoptosis in RGCs. Annexin V-positive and
PI-negative cells were considered to be the apoptotic cells.
After treatment with 200 µM CoCl2 for 24 h, the percentage
of apoptotic cells increased significantly compared with the
percentage following treatment with 0 µM CoCl2 (P < 0.01,
Figures 1D,E). Once our experimental conditions were set
up and the use of CoCl2 as an effective apoptosis inductor
confirmed, the 200 µM concentration was chosen for further
investigations.
Baclofen Protected RGCs Against
CoCl2–Induced Apoptosis
First, to determine whether baclofen could affect the survival
of RGCs, CCK-8 assays were performed, and the results
showed that cell viability was not significantly altered after
24 h of exposure to baclofen at concentrations up to 800 µM,
which indicates that, under certain conditions, baclofen has no
significant influence on RGC viability (Figure 2A). Furthermore,
we explored the effects of baclofen on cobalt-challenged
RGCs. We found that baclofen decreased the levels of cleaved
caspase-3 and bax and increased the expression of bcl-2
compared with those of hypoxic RGCs without baclofen
and that the effect was dose-dependent (Figures 2B,C). At
a concentration of 100 µM, the levels of apoptosis-related
proteins were changed significantly. The levels of cell
apoptosis detected by annexin V/PI double-stained flow
cytometry also showed that baclofen significantly counteracted
hypoxia-induced apoptosis in RGCs (P < 0.01, Figures 2D,E).
To further confirm the protective effects of baclofen against
hypoxia-induced cell death, we used Hoechst staining to
FIGURE 1 | Cobalt chloride (CoCl2) induces retinal ganglion cells (RGCs) apoptosis. (A) Cell viability detected by Cell Counting Kit-8 (CCK-8) assay in RGCs
treated with indicated concentrations of CoCl2 for 24 h. Data are means ± SD of three independent experiments. ∗p < 0.05, ∗∗p < 0.01 vs. basal level. (B,C)
Expression of cleaved caspase-3, bax and bcl-2 detected by Western blotting in RGCs treated with indicated concentrations of CoCl2 for 24 h. The corresponding
densitometric analyses of the protein bands detected in the immunoblots and normalized to the signal of α-tubulin are also shown. The level of protein in each group
was expressed as the value relative to the control. Data are means ± SD of three independent experiments. ∗∗p < 0.01, compared with the control. (D,E) Cell
apoptosis detected by Annexin V and propidium iodide (PI) staining methods in RGCs treated with indicated concentrations of CoCl2 for 24 h. The C3 quadrant
(Annexin V−/PI−), C4 quadrant (Annexin V + /PI−) and C2 quadrant (Annexin V + /PI+) indicate the percentage of viable cells, apoptotic cells and necrotic cells,
respectively. The percentage of apoptotic cells following CoCl2 treatment compared with the control group. Values represent the mean ± SD of three independent
experiments. ∗∗P < 0.01.
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FIGURE 2 | Baclofen protected RGCs against CoCl2-induced apoptosis without interfering cell viability of RGCs. (A) Cell viability detected by CCK-8
assay in RGCs treated with indicated concentrations of baclofen for 24 h. Data are means ± SD of three independent experiments. ∗p < 0.05, ∗∗p < 0.01 vs. basal
level. (B,C) Expression of cleaved caspase-3, bax and bcl-2 detected by Western blotting in RGCs treated with indicated concentrations of CoCl2 and baclofen for
24 h. The detected protein bands are normalized to the signal of α-tubulin. The protein levels were expressed as the value relative to the control. The data represent
the mean ± SD of three independent experiments. (∗p < 0.05, ∗∗p < 0.01 compared to control). (D,E) Cell apoptosis detected by Annexin V and PI staining methods
(Continued)
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FIGURE 2 | Continued
in RGCs treated with indicated concentrations of CoCl2 and baclofen for 24 h.
C4 quadrant (Annexin V + /PI−) indicates the percentage of apoptotic cells.
Values represent the mean ± SD of three independent experiments.
∗∗P < 0.01 vs. basal level. (F,G) RGCs stained with Hoechst nuclear stain after
treatment with indicate concentrations of CoCl2 and baclofen for 24 h, and
representative experiments are shown. Values represent the mean ± SD of
three independent experiments. ∗P < 0.05 vs. basal level. White arrows
indicate the apoptotic nuclei. (H,I) Terminal deoxynucleotidyl
transferase-mediated dUTP nick end-labeling (TUNEL) staining was used to
evaluate hypoxia-induced cell death. Cells were exposed to indicate
concentrations of CoCl2 and baclofen for 24 h. Apoptotic nuclei were
visualized by TUNEL. Representative experiments are shown (Final
magnification, ×40). Values represent the mean ± SD of three independent
experiments. ∗∗P < 0.01 vs. basal level. White arrows indicate the apoptotic
nuclei. (J,K) TUNEL-positive cells detected by flow cytometry. Representative
experiments are shown. Values represent the mean ± SD of three
independent experiments. ∗∗∗P < 0.001 vs. basal level.
detect apoptotic characteristics and TUNEL staining to detect
DNA fragmentation and cell death in hypoxia RGCs with
or without baclofen treatment. We treated RGCs with 100
µM baclofen and 200 µM CoCl2 for 24 h before performing
Hoechst and TUNEL staining. Baclofen significantly decreased
the percentage of apoptotic cells detected by both Hoechst
and TUNEL staining (Hoechst: P < 0.05, Figures 2F,G;
TUNEL: P < 0.01, Figures 2H,I; P < 0.001, Figures 2J,K).
Taken together, these results suggest that baclofen protects
RGCs from hypoxia-induced apoptosis without disturbing cell
viability.
Phosphorylation of Akt is Reduced and the
PERK-eIF2α-ATF4 Pathway is Activated in
Hypoxia-Treated RGCs, and Baclofen can
Reverse the Change
The Akt pathway has been shown to be involved with various
physiological and pathological process, including tumorigenesis
and hypoxia (Di et al., 2015; Liu et al., 2015; Zhu et al.,
2015). In RGCs, cobalt induced a significant decrease in
the level of phosphorylated Akt without altering the total
Akt expression level (Figures 3A,B). The rapid and transient
decrease in Akt phosphorylation began at 10 min and lasted
until 24 h after the application of the drug (Figures 3A,E).
In previous studies, endoplasmic reticulum (ER) stress has
been identified as a major mechanism of apoptosis in various
types of cells (Chen et al., 2015a; Hiramatsu et al., 2015;
López-Hernández et al., 2015). Our present study indicates
that hypoxia induces ER stress by activating the PERK-eIF2α-
ATF4 pathway. After 12 h of cobalt challenging, the levels of
phosphorylated PERK, phosphorylated eIF2α, and ATF4 were
significantly increased, while the levels of total PERK and
total eIF2α were not significantly changed. In addition, the
level of CCAAT/enhancer-binding protein homologous protein
(CHOP) protein was found to be upregulated after 12 h of
CoCl2 treatment (Figures 3C,D). The CHOP pathway is the
best-characterized pathway that has been reported to be involved
in ER stress-induced apoptosis (Li et al., 2014a; López-Hernández
et al., 2015).
We then explored the beneficial effects of baclofen on
hypoxia-mediated stress in RGCs. We pretreated RGCs with
baclofen and with or without CoCl2 for 24 h and then
determined the levels of the relevant proteins using western
blot analysis. As described above, baclofen had no negative
effect on RGC survival, and western blotting indicated
that baclofen did not change the Akt, PERK-pathway or
CHOP protein levels compared with those of the control
group. In the hypoxia treatment group, the administration
of baclofen significantly increased the phosphorylated Akt
level and decreased the phosphorylated PERK, phosphorylated
eIF2α, ATF4 and CHOP levels following hypoxic injury
(Figures 3E,F).
Baclofen Mediated RGC Apoptosis via the
GABAB Receptor
Baclofen is an agonist of the GABAB receptor. To understand
the role of the GABAB receptor in the baclofen-mediated
protection from apoptosis for hypoxic RGCs, GABAB2 was
knocked down by short interfering (si) RNA. Both qRT-
PCR and western blot assays showed that siRNA2 knockdown
of GABAB2, for both RNA and protein levels, was more
effective than that of siRNA1 and siRNA3 (Figures 4A–C). To
determine the effect of GABAB2 knockdown on cell viability
and apoptosis, CCK8 assays, western blotting and annexin V/PI
double-stained flow cytometry were performed. Cell viability was
not significantly changed by GABAB2 silencing (Figure 4D).
Flow cytometry (Figures 4E,F) and western blot analysis
(Figures 4G,H) showed that GABAB2 depletion had no effect on
RGC apoptosis.
As observed in the hypoxia-treated RGCs, flow cytometry
results indicated that GABAB2 depletion abolished the
baclofen-induced decrease in hypoxia-induced RGC apoptosis
(Figures 5A,B). Hoechst staining revealed similar results
and indicated that the knockdown of GABAB2 decreased
baclofen’s protective effect on hypoxic RGCs compared the
effect observed in the siRNA-control group (Figures 5C,D).
The expression levels of cleaved caspase-3, bax and bcl-2 in
the GABAB2-knockdown hypoxic RGCs treated with baclofen
were similar to those without baclofen treatment. In the
siRNA-control groups, baclofen significantly reduced the
levels of cleaved caspase-3 and bax and increased the level
of bcl-2 in hypoxic RGCs (Figures 5E,F). We next explored
the relationship between the GABAB receptor and Akt, the
PERK-eIF2α-ATF4 pathway and CHOP. In GABAB2-depleted
RGCs, baclofen did not significantly change the levels of
Akt, PERK-pathway and CHOP proteins under hypoxic
conditions compared with the levels in the baclofen-free group.
However, in the siRNA-control RGCs, the administration
of baclofen significantly increased the phosphorylation of
the Akt protein and decreased the levels of phosphorylated
PERK, phosphorylated eIF2α, ATF4 and CHOP after hypoxic
injury, compared with the levels of the baclofen-free group
(Figures 5G,H). These data indicate that the GABAB receptor
is required for the baclofen-induced protective effect on hypoxic
RGCs.
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FIGURE 3 | Phosphorylation of Akt is reduced and protein kinase RNA (PKR)-like ER kinase (PERK)-eIF2α-ATF4 pathway is activated in
hypoxia-treated RGCs, and baclofen can reverse the change. (A,B) Time dependent expression of total Akt and phosphorylated Akt induced by 200 µM
CoCl2. Representative experiments are presented. The detected protein bands are normalized to the signal of α-tubulin. Protein level in each group was expressed
as the value relative to the control. The data represent the mean ± SD of three independent experiments. (∗p < 0.05, compared to control). (C,D) Time dependent
expression of indicated proteins induced by 200 µM CoCl2. (E,F) Expression of indicated proteins detected by Western blotting in RGCs treated with baclofen and
CoCl2 for 24 h as presented. Protein expression is shown as percentage of control cells unexposed to chemotherapeutic drugs. The data represent the mean ± SD
of three independent experiments (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 compared to cells without CoCl2 or baclofen treatment).
Inhibition of Akt Phosphorylation
Abolished the Protection by Baclofen
Against Hypoxia-Induced Apoptosis in
RGCs
As mentioned above, the Akt pathway was shown to be activated
during the protection by baclofen against hypoxia-induced
apoptosis in RGCs. To understand the role of the activation
of the Akt pathway in this protective process, an inhibitor
of Akt phosphorylation (MK-2206 2HCl) was applied.
According to the manufacture, MK-2206 2HCl blocks Akt
phosphorylation without changing the total Akt level. Annexin
V/PI double-stained flow cytometry results indicated that
baclofen did not significantly reduce the percentage of apoptotic
cells in the RGCs treated with MK-2206 2HCl compared with
that in the CoCl2-treated group. Meanwhile, in the RGCs
without MK-2206 2HCl treatment, baclofen significantly
reduced the percentage of apoptotic cells compared with that
in the CoCl2-treated group (P < 0.01; Figures 6A,B). Hoechst
assays showed that the inhibition of Akt phosphorylation
failed to reduce the percentage of apoptotic cells compared
with that in the CoCl2-treated group (Figures 6C,D). Western
blotting demonstrated that inhibiting Akt phosphorylation
in hypoxic RGCs did not significantly change the levels
of cleaved caspase-3, bax and bcl-2 regardless of baclofen
treatment (Figures 6E,F). Moreover, western blot assays
indicated that the inhibition of Akt phosphorylation increased
the basal levels of PERK phosphorylation in hypoxic RGCs,
as well as those of phosphorylated eIF2α, ATF4 and CHOP,
which were not further decreased after baclofen treatment
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FIGURE 4 | Small interfering RNA (siRNA) silenced GABAB2 expression without interfering RGCs survival. (A–C) GABAB2 mRNA expression (A) and
GABAB2 protein level (B,C). Up on transfected with siRNAs against GABAB2 and control siRNA. ∗∗p < 0.01, ∗∗∗p < 0.001 vs. basal level. (D) Time course of cell
viability detected by CCK-8 assay in RGCs transfected with indicated siRNAs. Cell viability was quantified based on three independent experiments (mean ± SD).
(E,F) Expression of cleaved caspase-3, bax and bcl-2 detected by Western blotting in RGCs transfected with indicated siRNAs. The detected protein bands are
normalized to the signal of α-tubulin. The level of protein in each group was expressed as the value relative to the control. The data represent the mean ± SD of three
independent experiments. (∗p < 0.05, vs. control). (G,H) Cell apoptosis detected by Annexin V and PI staining methods in RGCs transfected with indicated siRNAs.
C4 quadrant (Annexin V + /PI−) indicates the percentage of apoptotic cells. Representative experiments are shown. Values represent the mean ± SD of three
independent experiments.
(Figures 6G,H). Together, these results indicate that Akt
phosphorylation is necessary for baclofen’s protective effect
against hypoxia-induced apoptosis and the activation of ER
stress in RGCs.
DISCUSSION
Hypoxia, in vitro and in vivo, triggers mixed cell death
due to both necrosis and apoptosis. Previously, studies have
indicated that baclofen has pharmacological effects against
cell apoptosis in various types of cells (Naseer et al., 2013;
Tian et al., 2013; Liu et al., 2015). However, no data have
yet been reported in an in vitro experiment related to
RGCs. Thus, we investigated the use of an in vitro model
of purified rat RGC cultures to examine whether baclofen
has neuroprotective effects against RGC apoptosis induced by
hypoxic stress.
It has been reported that ganglion cells in diabetic retinas
express several proapoptosis molecules, suggesting that these
cells are among the most vulnerable neurons (Abu-El-Asrar
et al., 2004). Following study revealed that in superoxide
dismutase 1 (SOD1)-deficient mice, RGC degeneration precedes
the degeneration of other layers in retina, indicating the greater
vulnerability of RGCs to oxidative stress compared with other
neurons (Yuki et al., 2011).
While it is difficult to control oxygen levels precisely to
simulate hypoxic condition in cell culture, various in vitro
models of neuronal hypoxia have been provided using divalent
cations such as cobalt (Montel et al., 2007; Hang et al.,
2009; Lopez-Sánchez et al., 2014; Yang et al., 2016). Cobalt
have been applicable to mimic hypoxic conditions in cultured
cells because they activate hypoxic signals by stabilizing
the expression of hypoxia-inducible factor-1 alpha (HIF-
1α), an O2-regulated transcriptional activator. Studied have
verified that incubation of cells with CoCl2 mimics the
hypoxia situation confirmed by the observed increase of
VEGF protein expression and secretion vs. normoxia (Carbajo-
Pescador et al., 2013). Increased HIF-1α leval in cells cultured
in hypoxia-mimetic agent treated cells are similar to those
observed in a hypoxia chamber (1% O2; Liu et al., 2014).
Thus in this study, CoCl2 was added at a final concentration
of 200 mM to mimic hypoxia. We demonstrated that
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FIGURE 5 | Baclofen mediated RGCs apoptosis via GABAB receptor. (A,B) RGCs were transfected with GABAB2 siRNA2 or control siRNA before treatment
with CoCl2 and baclofen for 24 h as indicated. Cell apoptosis detected by Annexin V and PI staining methods. C2, C4 quadrant (Annexin V + /PI−) indicate the
percentage of necrotic or apoptotic cells, respectively. Values represent the mean ± SD of three independent experiments. ∗∗P < 0.01 vs. basal level. (C,D) RGCs
stained with Hoechst nuclear stain after treatment as described above. White arrows indicate the apoptotic nuclei. Values represent the mean ± SD of three
independent experiments. ∗P < 0.05 vs. basal level. (E–H) RGCs were transfected with GABAB2 siRNA2 or control siRNA before treatment with CoCl2 and baclofen.
(Continued)
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FIGURE 5 | Continued
Expression of apoptosis related proteins (E,F) and pathway related proteins
(G,H) detected by Western blotting treated with baclofen and CoCl2 for 24 h
as presented. α-tubulin served as a loading control. The level of protein in each
group was expressed as the value relative to the control. The data represent
the mean ± SD of three independent experiments. (∗p < 0.05, vs. control).
mimicking hypoxia in vitro by using CoCl2 is capable of
inducing apoptosis in primary RGC cell culture in a dose
dependent way.
Based on the current results, we showed that baclofen
protects RGCs against apoptosis via the GABAB receptor
in hypoxic culture conditions. The GABAB receptor is an
allosteric complex made of two subunits, GABAB1 and GABAB2.
GABAB2 plays a major role in coupling to G proteins,
whereas GABAB1 binds GABA. GABAB2’s association with
GABAB1 plays a crucial role in the agonist-induced GABAB
receptor activation (Liu et al., 2004; Pin et al., 2004). Thus,
the depletion of GABAB2 abolished the baclofen-induced
GABAB receptor activation and prevented the GABAB receptor
from binding with the G protein, which prevented the
subsequent signaling pathway cascade. In the present study,
we demonstrated that the siRNA-mediated knockdown of
GABAB2 inhibits the protective effect of baclofen on RGCs
in cobalt-challenged condition, which confirmed the specific
involvement of the GABAB receptor in the protective effect of
baclofen.
Moreover, our present study demonstrates that baclofen
effectively prevented hypoxia-induced apoptosis by
downregulating the expression of cleaved caspase-3 and
bax and increasing the expression of bcl-2 in RGCs. The
hypoxia-induced caspase-3 activation, bax upregulation and
bcl-2 downregulation in various cells are reversed by the
activation of the PI3K/Akt signaling pathway, which leads to the
acquisition of antiapoptotic properties (Mounir et al., 2011; Chen
et al., 2015b; Zhang et al., 2015). The expression of antiapoptotic
and proapoptotic proteins, especially caspase-3, bax and bcl-2,
determines the susceptibility to apoptosis (Wei et al., 2001;
Sadidi et al., 2009). We therefore investigated whether these
pathways were involved in the antiapoptotic effects of baclofen
in RGCs. The caspase-3 and bcl-2/bax apoptotic signaling
pathways mediate the protective effects of baclofen in neurons
(Tyurenkov et al., 2012; Li et al., 2014b), lung tissue (Jin et al.,
2015) and pancreatic β-cells (Tian et al., 2013). Our result
revealed that baclofen reduced caspase-3 activity and increased
the bcl-2/bax level, suggesting that baclofen inhibits RGC
apoptosis through the regulation of the activity of caspase-3 and
of bcl-2/bax expression, which is consistent with the results of
previous studies. Moreover, we found that Akt and the PERK
and CHOP pathways were involved in the protective effects of
baclofen.
In this study, we demonstrated that, in hypoxic RGCs, the
activity of Akt was much higher in the baclofen-treated group
than that in the hypoxic control group. Numerous studies have
shown that the phosphatidylinositol 3-kinase–Akt (PI3K/AKT)
signaling pathway plays a major role in cell apoptosis (Tu et al.,
2010; Shilpa et al., 2013; Purwana et al., 2014; Di et al., 2015; Liu
et al., 2015). The specific involvement of the GABAB receptor
in Akt activation has been investigated in several types of cells.
It has been reported that the PI3K/AKT signaling pathway is
altered when retinal cells are exposed to oxidative stress, which
can subsequently alter downstream signaling cascades (Wang
et al., 2008). In cerebellar granule neurons, the GABAB receptor
agonist baclofen protect neurons from apoptosis through the
regulation of bcl-2/bax or caspase-3 via the PI3K/Akt pathway
(Tu et al., 2010; He et al., 2014; Liu et al., 2015). To understand
whether the increase in Akt phosphorylation is necessary for
the protective effects of baclofen on RGCs, an inhibitor of Akt
phosphorylation was applied. Inhibition of Akt phosphorylation
abolished the protection by baclofen against hypoxia-induced
apoptosis in RGCs, and the levels of cleaved caspase-3, bax and
bcl-2 did not change significantly when Akt phosphorylation
was blocked regardless of baclofen treatment. These data
demonstrate that Akt activation is one of the essential processes
involved in the neuroprotective effect of baclofen on hypoxic
RGCs.
Apoptosis is tightly controlled by a variety of signaling
pathways that either promote or inhibit the apoptotic cascades.
Recent evidence suggests that disturbed protein homeostasis and
ER stress contribute to apoptosis in retinal cells (Jing et al.,
2012). Several lines of evidence point to a strong relationship
between hypoxia and the accumulation of misfolded proteins in
the ER (Hiramatsu et al., 2015) leading to the unfolded protein
response (UPR), which is toxic to cells. Moreover, ER stress
activates a large number of genes involved in the control of
cell fate, including antiapoptotic and proapoptotic molecules
such as bax and bcl-2 (Mounir et al., 2011). Therefore, we
clarified the role of ER stress in RGC apoptosis, as well as
the relationship between baclofen’s protective effect and ER
stress.
Three ER-related proteins, PERK (Harding et al., 1999),
activating transcription factor 6 (ATF6; Ron and Walter, 2007)
and inositol-requiring enzyme-1 (IRE1; Tirasophon et al., 1998;
Calfon et al., 2002), are involved in the initial signaling to the
cell through the UPR. Initially, ER stress leads to adaptations
to the changing environment and the restoration of normal ER
function. However, during prolonged or overwhelming ER stress,
the UPR fails to restore normal ER function, and apoptotic
cascades can be activated (Sano and Reed, 2013; Williams et al.,
2014).
Previous studies demonstrated that increased ER stress
in apoptotic RGC degeneration is accompanied by increased
ER stress-related proteins, such as Bip, PERK and CHOP
(Shimazawa et al., 2007; Doh et al., 2010). Our present
research indicates that hypoxia-induced ER stress was initiated
in RGCs via the activation of the PERK pathway, which
could be reduced by baclofen treatment, while ATF6 and
IRE1 levels were not significantly changed (data not shown).
Furthermore, both the depletion of the GABAB receptor and
the inhibition of Akt activation increased the basal levels of the
PERK-pathway proteins (PERK/eIF2α/ATF4) in cobalt-treated
RGCs, which were not decreased following baclofen treatment.
Together, these data indicate that baclofen protects RGCs
from hypoxia-induced apoptosis by downregulating the PERK
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FIGURE 6 | Akt phosphorylation is needed for baclofen mediating RGCs apoptosis. (A,B) Cell apoptosis detected by Annexin V and PI staining methods in
RGCs treated with CoCl2, baclofen and Akt inhibitor for 24 h as indicated. C4 quadrant (Annexin V + /PI−) indicates the percentage of apoptotic cells. Values
represent the mean ± SD of three independent experiments. ∗∗P < 0.01 vs. basal level. (C,D) RGCs stained with Hoechst nuclear stain after treatment as
(Continued)
Frontiers in Cellular Neuroscience | www.frontiersin.org 11 November 2016 | Volume 10 | Article 255
Fu et al. Baclofen Protects RGCs from CoCl2-Mimicked Hypoxia
FIGURE 6 | Continued
described above. White arrows indicate the apoptotic nuclei. Values represent
the mean ± SD of three independent experiments. ∗∗P < 0.01 vs. basal level.
(E–H) Expression of apoptosis related proteins (E,F) and pathway related
proteins (G,H) detected by Western blotting in RGCs treated with baclofen,
CoCl2 and Akt inhibitor for 24 h as presented. α-tubulin was included as a
loading control. Protein levels were expressed as the value relative to the
control in each group. The data represent the mean ± SD of three
independent experiments. (∗p < 0.05, vs. control).
pathway, which is regulated by the GABAB receptor and the Akt
pathway.
CHOP is a major stress-inducible proapoptotic gene involved
in ER stress-induced apoptosis (Wang and Ron, 1996). All
three branches of the UPR regulate the activation of CHOP (Li
et al., 2014a); however, ATF4 is considered to be the major
inducer of CHOP expression (Jing et al., 2012; Li et al., 2014a).
Recent studies show that both the antiapoptotic gene bcl-2
and the proapoptotic protein bax (apoptosis-associated proteins
that localize on the mitochondrial membrane) are regulated by
CHOP during ER stress (McCullough et al., 2001; Puthalakath
et al., 2007). This provides evidence that the proapoptotic
functions of CHOP are associated with mitochondria-dependent
mechanisms of cell death. Our data support this premise, which
was substantiated by the observations of increased caspase-3
activity in hypoxia-treated RGCs. CHOP was down regulated
by baclofen in hypoxic RGCs, however, this down regulation
was abolished by the depletion of the GABAB receptor or the
inhibition of Akt activation.
In conclusion, this study demonstrates the beneficial effects
of baclofen, a GABAB receptor agonist, in the treatment of
hypoxia-induced apoptosis in RGCs. Baclofen exerted its effects
in protecting hypoxic RGCs from apoptosis by activating
the GABAB receptor, upregulating Akt phosphorylation and
downregulating the PERK pathway during ER stress, as well
as by downregulating CHOP, which finally downregulated the
levels of the proapoptotic proteins cleaved caspase-3 and bax
and upregulated the antiapoptotic protein bcl-2. These results
identify baclofen as an effective regulator of Akt and PERK
signaling in RGCs, and offers insight on the role of baclofen in
regulating the neuron survival in cellular pathology associated
with hypoxic ischemic disorders of retina. Baclofen could be a
potentially useful therapeutic drug for the treatment of retinal
hypoxia diseases.
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